Tapewire

Nasdaq · USD

WHWK

Whitehawk Therapeutics, Inc.

Export transactions ↓
Tapewire entity
6074
SEC CIK
0001422142
Parsed reports
260

Last 12 months

Inside the activity.

0 purchase rows · 14 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202603
Apr 2026011
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 03, 2024 Filed Oct 3, 2024 23:03 UTC
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
SaleCommon Stock 9,689 $1.94 $18,796.66
Disclosure

SEC source: 0001415889-24-024676 · form4-10032024_111036.xml · nonDerivative · entry 2

Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,869

F2 · kind: Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 23:03 UTC
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionRestricted Stock Units · Derivative 32,558 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-024676 · form4-10032024_111036.xml · derivative · entry 3

Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 32,558 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.

F3 · derivative.exercise_date: One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024.

F3 · derivative.expiration_date: One hundred percent (100%) of the RSUs subject to the award vested on October 2, 2024.

Read SEC document
October 02, 2024 Filed Oct 3, 2024 23:03 UTC
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
Exercise / conversionCommon Stock 32,558 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-024676 · form4-10032024_111036.xml · nonDerivative · entry 1

Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,558

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.

Read SEC document
September 03, 2024 Filed Sep 5, 2024 21:55 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 40,000 $1.71 $68,316.00
Disclosure

SEC source: 0001415889-24-022964 · form4-09052024_090938.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,171,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $1.63 to $1.82 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
August 05, 2024 Filed Aug 5, 2024 22:49 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 5,652 $1.34 $7,594.59
Disclosure

SEC source: 0001415889-24-020784 · form4-08052024_100800.xml · nonDerivative · entry 3

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,211,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F5 · price: Represents the weighted average share price of an aggregate total of 5,652 shares sold in the price range of $1.31 to $1.38 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
August 02, 2024 Filed Aug 5, 2024 22:49 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 18,933 $1.41 $26,705.00
Disclosure

SEC source: 0001415889-24-020784 · form4-08052024_100800.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,217,195

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 18,933 shares sold in the price range of $1.38 to $1.47 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
August 01, 2024 Filed Aug 5, 2024 22:49 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 15,415 $1.50 $23,054.67
Disclosure

SEC source: 0001415889-24-020784 · form4-08052024_100800.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,236,128

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 15,415 shares sold in the price range of $1.47 to $1.53 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
July 02, 2024 Filed Jul 2, 2024 22:37 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 8,652 $1.34 $11,611.85
Disclosure

SEC source: 0001415889-24-019045 · form4-07022024_100754.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,251,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 8,652 shares sold in the price range of $1.32 to $1.40 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
July 01, 2024 Filed Jul 2, 2024 22:37 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 31,348 $1.45 $45,605.07
Disclosure

SEC source: 0001415889-24-019045 · form4-07022024_100754.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,260,195

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 31,348 shares sold in the price range of $1.4201 to $1.52 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:12 UTC
Aghazadeh BehzadDirector · 10% owner · See remarks
Avoro Capital Advisors LLCDirector · 10% owner · See remarks
Avoro Ventures LLCDirector · 10% owner · See remarks
GrantStock Option (right to buy) · Derivative 45,832 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001415889-24-016874 · form4-06142024_080636.xml · derivative · entry 1

Aghazadeh Behzad · CIK 0001701815 · Director · 10% owner · See remarks

Avoro Capital Advisors LLC · CIK 0001633313 · Director · 10% owner · See remarks

Avoro Ventures LLC · CIK 0001879253 · Director · 10% owner · See remarks

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Common Stock · 45,832 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

F2 · balance_after: This Form 4 is filed by Avoro Capital Advisors LLC, a Delaware limited liability company ("Avoro Capital Advisors"), Avoro Ventures LLC, a Delaware limited liability company ("Avoro Ventures") and Behzad Aghazadeh ("Dr. Aghazadeh", and together with Avoro Capital Advisors and Avoro Ventures, the "Reporting Persons"). Dr. Aghazadeh serves as the portfolio manager and controlling person of Avoro Capital Advisors and Avoro Ventures LLC.

F3 · balance_after: The filing of this statement shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:11 UTC GrantStock Option (right to buy) · Derivative 45,832 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001415889-24-016873 · form4-06142024_080605.xml · derivative · entry 1

Maroun Richard E · CIK 0001364590 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Common Stock · 45,832 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:10 UTC GrantStock Option (right to buy) · Derivative 45,832 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001415889-24-016872 · form4-06142024_080614.xml · derivative · entry 1

Hirmand Mohammad · CIK 0001654482 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Common Stock · 45,832 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:09 UTC
Reeve EmmaDirector
GrantStock Option (right to buy) · Derivative 45,832 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001415889-24-016870 · form4-06142024_080619.xml · derivative · entry 1

Reeve Emma · CIK 0001680329 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Common Stock · 45,832 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:06 UTC GrantStock Option (right to buy) · Derivative 45,832 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001415889-24-016868 · form4-06142024_080632.xml · derivative · entry 1

Castelein Caley · CIK 0001355758 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Common Stock · 45,832 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:05 UTC
Dalal AnupamDirector
GrantStock Option (right to buy) · Derivative 45,832 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001415889-24-016865 · form4-06142024_080626.xml · derivative · entry 1

Dalal Anupam · CIK 0001602474 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Common Stock · 45,832 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

Read SEC document
June 12, 2024 Filed Jun 14, 2024 20:03 UTC GrantStock Option (right to buy) · Derivative 45,832 $0.00 Strike: $1.70 $0.00
Disclosure

SEC source: 0001415889-24-016862 · form4-06142024_080653.xml · derivative · entry 1

Hehenberger Karin M. · CIK 0001548029 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,832

Underlying: Common Stock · 45,832 shares

Expires 2034-06-12

F1 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the day immediately prior to the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 12, 2024.

Read SEC document
June 04, 2024 Filed Jun 5, 2024 20:25 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 20,225 $1.77 $35,745.67
Disclosure

SEC source: 0001415889-24-015561 · form4-06052024_080618.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,291,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 20,225 shares sold in the price range of $1.73 to $1.81 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
June 03, 2024 Filed Jun 5, 2024 20:25 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 19,775 $1.81 $35,765.07
Disclosure

SEC source: 0001415889-24-015561 · form4-06052024_080618.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,311,768

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 19,775 shares sold in the price range of $1.79 to $1.89 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
May 01, 2024 Filed May 2, 2024 00:50 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 40,000 $1.93 $77,184.00
Disclosure

SEC source: 0001415889-24-011937 · form4-05022024_120534.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,331,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 40,000 shares sold in the price range of $1.885 to $1.975 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
April 02, 2024 Filed Apr 3, 2024 20:49 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 22,228 $2.23 $49,512.87
Disclosure

SEC source: 0001415889-24-010037 · form4-04032024_080413.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,371,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 22,228 shares sold in the price range of $2.185 to $2.28 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
April 01, 2024 Filed Apr 3, 2024 20:49 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 17,772 $2.31 $41,101.30
Disclosure

SEC source: 0001415889-24-010037 · form4-04032024_080413.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,393,771

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 17,772 shares sold in the price range of $2.28 to $2.35 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
March 04, 2024 Filed Mar 5, 2024 00:22 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 14,964 $2.10 $31,415.42
Disclosure

SEC source: 0001415889-24-006421 · form4-03052024_120319.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 1,411,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 14,964 shares sold in the price range of $2.02 to $2.175 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 00:22 UTC
Desai NeilDirector · EXECUTIVE CHAIRMAN
SaleCommon Stock 27,036 $1.97 $53,225.77
Disclosure

SEC source: 0001415889-24-006421 · form4-03052024_120319.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · EXECUTIVE CHAIRMAN

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,426,507

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 27,036 shares sold in the price range of $1.93 to $1.995 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 19:18 UTC
ITRI LORETTTA MCHIEF MEDICAL OFFICER
GrantRestricted Stock Units · Derivative 30,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-006416 · form4-03052024_120358.xml · derivative · entry 3

ITRI LORETTTA M · CIK 0001137918 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.

F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

F4 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 19:18 UTC
ITRI LORETTTA MCHIEF MEDICAL OFFICER
GrantStock option (right to buy) · Derivative 60,000 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0001415889-24-006416 · form4-03052024_120358.xml · derivative · entry 2

ITRI LORETTTA M · CIK 0001137918 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2034-03-01

F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 4, 2024 19:18 UTC
ITRI LORETTTA MCHIEF MEDICAL OFFICER
GrantStock option (right to buy) · Derivative 76,813 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0001415889-24-006416 · form4-03052024_120358.xml · derivative · entry 1

ITRI LORETTTA M · CIK 0001137918 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,813

Underlying: Common Stock · 76,813 shares

Expires 2034-03-01

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date. "Grant Date" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 00:15 UTC
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
GrantRestricted Stock Units · Derivative 65,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-006414 · form4-03052024_120318.xml · derivative · entry 3

Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.

F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

F4 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 00:15 UTC
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
GrantStock Option (right to buy) · Derivative 130,000 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0001415889-24-006414 · form4-03052024_120318.xml · derivative · entry 2

Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Common Stock · 130,000 shares

Expires 2034-03-01

F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 00:15 UTC
Lennon David JamesDirector · CHIEF EXECUTIVE OFFICER
GrantStock option (right to buy) · Derivative 30,768 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0001415889-24-006414 · form4-03052024_120318.xml · derivative · entry 1

Lennon David James · CIK 0001995275 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,768

Underlying: Common Stock · 30,768 shares

Expires 2034-03-01

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date. "Grant Date" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 00:12 UTC
Giacobello Scott M.CHIEF FINANCIAL OFFICER
GrantRestricted Stock Units · Derivative 27,000 $0.00 $0.00
Disclosure

SEC source: 0001415889-24-006411 · form4-03052024_120310.xml · derivative · entry 3

Giacobello Scott M. · CIK 0001754154 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,000

Underlying: Common Stock · 27,000 shares

Expires not disclosed

F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.

F4 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

F4 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date, and twenty five percent (25%) of the shares subject to the award shall vest each of the next three Vesting Commencement Date anniversaries thereafter. "Vesting Commencement Date" shall mean March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 00:12 UTC
Giacobello Scott M.CHIEF FINANCIAL OFFICER
GrantStock Option (right to buy) · Derivative 55,000 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0001415889-24-006411 · form4-03052024_120310.xml · derivative · entry 2

Giacobello Scott M. · CIK 0001754154 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Common Stock · 55,000 shares

Expires 2034-03-01

F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the Option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean March 1, 2024.

Read SEC document
March 01, 2024 Filed Mar 5, 2024 00:12 UTC
Giacobello Scott M.CHIEF FINANCIAL OFFICER
GrantStock Option (right to buy) · Derivative 138,263 $0.00 Strike: $1.92 $0.00
Disclosure

SEC source: 0001415889-24-006411 · form4-03052024_120310.xml · derivative · entry 1

Giacobello Scott M. · CIK 0001754154 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,263

Underlying: Common Stock · 138,263 shares

Expires 2034-03-01

F1 · derivative.exercise_date: One hundred percent (100%) of the shares subject to the option shall be fully vested on the Grant Date, subject to such Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the Grant Date. "Grant Date" shall mean March 1, 2024. This option comprises a portion of the Reporting Person's bonus for 2023 performance.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 22:04 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 42,000 $1.74 $73,269.00
Disclosure

SEC source: 0001209191-24-002684 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 1,453,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 42,000 shares sold in the price range of $1.72 to $1.84 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 00:48 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 42,000 $2.06 $86,549.40
Disclosure

SEC source: 0001209191-24-000254 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,495,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 42,000 shares sold in the price range of $2.00 to $2.10 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
December 06, 2023 Filed Dec 7, 2023 21:04 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 7,037 $4.82 $33,914.12
Disclosure

SEC source: 0001209191-23-057713 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,537,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 7,037 shares sold in the price range of $4.64 to $4.92 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
December 05, 2023 Filed Dec 5, 2023 23:40 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 15,740 $5.02 $78,940.82
Disclosure

SEC source: 0001209191-23-057545 · doc4.xml · nonDerivative · entry 3

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,544,580

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F5 · price: Represents the weighted average share price of an aggregate total of 15,740 shares sold in the price range of $4.85 to $5.2050 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
December 04, 2023 Filed Dec 5, 2023 23:40 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 10,876 $5.15 $55,986.39
Disclosure

SEC source: 0001209191-23-057545 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,560,320

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 10,876 shares sold in the price range of $5.04 to $5.24 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
December 01, 2023 Filed Dec 5, 2023 23:40 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 8,347 $5.14 $42,881.04
Disclosure

SEC source: 0001209191-23-057545 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,571,196

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 8,347 shares sold in the price range of $4.97 to $5.34 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
November 02, 2023 Filed Nov 2, 2023 22:45 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 31,662 $4.46 $141,104.87
Disclosure

SEC source: 0001209191-23-054214 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,579,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 31,662 shares sold in the price range of $4.35 to $4.61 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
November 01, 2023 Filed Nov 2, 2023 22:45 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 10,338 $4.32 $44,644.65
Disclosure

SEC source: 0001209191-23-054214 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,611,205

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 10,338 shares sold in the price range of $4.275 to $4.36 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
October 03, 2023 Filed Oct 3, 2023 22:51 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 16,431 $4.10 $67,303.02
Disclosure

SEC source: 0001209191-23-051697 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,621,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 16,431 shares sold in the price range of $3.97 to $4.32 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 22:51 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 25,569 $4.37 $111,698.18
Disclosure

SEC source: 0001209191-23-051697 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,637,974

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 25,569 shares sold in the price range of $4.17 to $4.88 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 22:49 UTC
Lennon David JamesDirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 490,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0001209191-23-051695 · doc4.xml · derivative · entry 2

Lennon David James · CIK 0001995275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 490,000

Underlying: Common Stock · 490,000 shares

Expires 2033-10-02

F3 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2023 Inducement Equity Incentive Plan) through each applicable date, twenty-five percent (25%) of the shares subject to the option shall vest one (1) year after the Date of Grant, and one-forty-eighth (1/48th) of the shares subject to the option shall vest monthly thereafter on the same day of the month as the Date of Grant (and if there is no corresponding day, the last day of the month), such that the option will be fully vested and exercisable four (4) years from the Date of Grant. "Date of Grant" shall mean October 2, 2023.

Read SEC document
October 02, 2023 Filed Oct 3, 2023 22:49 UTC
Lennon David JamesDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 32,558 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-051695 · doc4.xml · derivative · entry 1

Lennon David James · CIK 0001995275 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,558

Underlying: Common Stock · 32,558 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Aadi Bioscience, Inc. Common Stock.

F2 · derivative.exercise_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the RSUs subject to the award shall vest on October 2, 2024.

F2 · derivative.expiration_date: Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable date, one hundred percent (100%) of the RSUs subject to the award shall vest on October 2, 2024.

Read SEC document
September 06, 2023 Filed Sep 6, 2023 23:05 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 7,111 $5.29 $37,637.10
Disclosure

SEC source: 0001209191-23-048535 · doc4.xml · nonDerivative · entry 3

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,663,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F5 · price: Represents the weighted average share price of an aggregate total of 7,111 shares sold in the price range of $5.24 to $5.45 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
September 05, 2023 Filed Sep 6, 2023 23:05 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 21,000 $5.63 $118,316.10
Disclosure

SEC source: 0001209191-23-048535 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,670,654

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 21,000 shares sold in the price range of $5.46 to $5.91 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
September 01, 2023 Filed Sep 6, 2023 23:05 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 13,889 $5.97 $82,872.89
Disclosure

SEC source: 0001209191-23-048535 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,691,654

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 13,889 shares sold in the price range of $5.80 to $6.37 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
August 02, 2023 Filed Aug 3, 2023 20:22 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 19,290 $5.20 $100,250.13
Disclosure

SEC source: 0001209191-23-044439 · doc4.xml · nonDerivative · entry 2

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,705,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F4 · price: Represents the weighted average share price of an aggregate total of 19,290 shares sold in the price range of $5.09 to $5.30 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
August 01, 2023 Filed Aug 3, 2023 20:22 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 22,710 $5.22 $118,523.49
Disclosure

SEC source: 0001209191-23-044439 · doc4.xml · nonDerivative · entry 1

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,724,833

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F2 · price: Represents the weighted average share price of an aggregate total of 22,710 shares sold in the price range of $5.12 to $5.30 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document
July 06, 2023 Filed Jul 6, 2023 23:36 UTC
Desai NeilDirector · Executive Chairman
SaleCommon Stock 15,829 $6.27 $99,273.16
Disclosure

SEC source: 0001209191-23-041700 · doc4.xml · nonDerivative · entry 3

Desai Neil · CIK 0001878692 · Director · Executive Chairman

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,747,543

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan originally adopted on September 20, 2021, as replaced on December 1, 2022, by the Reporting Person.

F5 · price: Represents the weighted average share price of an aggregate total of 15,829 shares sold in the price range of $6.14 to $6.50 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F3 · ownership.nature: Shares held by Neil Prafulla Desai, Trustee of the Anishka Family Trust (the "Family Trust"). The Reporting Person is trustee of the Family Trust.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.